Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03903107 · ClinicalTrials.gov registry record · NA
The Fluoroless-CSP Trial Using Electroanatomic Mapping
A NA study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03903107 is a NA study that has completed, run by Rush University Medical Center. The registered enrollment target is 2 participants.
The verdict
NCT03903107, a NA study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The goal of this study is to assess the feasibility, accuracy and safety of performing fluoroless (or low fluoro) conduction system pacing utilizing electro-anatomic mapping (EAM) with the CARTO 3 mapping system (Biosense Webster Inc, Irvine, CA) in comparison to a group of patients undergoing conventional conduction system pacing (CSP) Implants.
Interventions
- PROCEDURE Conventional fluoroscopy guided Conduction System Pacing(CSP)
- PROCEDURE Electroanatomic Mapping (Fluoroless) guided Conduction System Pacing(CSP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-10-26 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03903107
The ClinicalTrials.gov registry entry for NCT03903107 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Conventional fluoroscopy guided Conduction System Pacing(CSP) is the first listed.
NCT03903107 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03903107 about?
NCT03903107 is a clinical study titled "The Fluoroless-CSP Trial Using Electroanatomic Mapping". The goal of this study is to assess the feasibility, accuracy and safety of performing fluoroless (or low fluoro) conduction system pacing utilizing electro-anatomic mapping (EAM) with the CARTO 3 mapping system (Biosense Webster Inc, Irvine, CA) in comparison to a group of patients undergoing conve...
What is the current status of trial NCT03903107?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2020-10-26. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT03903107?
The interventions under investigation include: Conventional fluoroscopy guided Conduction System Pacing(CSP) (PROCEDURE), Electroanatomic Mapping (Fluoroless) guided Conduction System Pacing(CSP) (PROCEDURE).
Who is sponsoring clinical trial NCT03903107?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.